ArticleNeurosurgery2017

Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma.

Wi Jin Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.